164 related articles for article (PubMed ID: 16680591)
1. Papillary microcarcinoma: is there any difference between clinically overt and occult tumors?
Lo CY; Chan WF; Lang BH; Lam KY; Wan KY
World J Surg; 2006 May; 30(5):759-66. PubMed ID: 16680591
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients.
Mercante G; Frasoldati A; Pedroni C; Formisano D; Renna L; Piana S; Gardini G; Valcavi R; Barbieri V
Thyroid; 2009 Jul; 19(7):707-16. PubMed ID: 19348581
[TBL] [Abstract][Full Text] [Related]
3. Incidental papillary microcarcinoma of the thyroid--factors affecting lymph node metastasis.
Gülben K; Berberoğlu U; Celen O; Mersin HH
Langenbecks Arch Surg; 2008 Jan; 393(1):25-9. PubMed ID: 17690905
[TBL] [Abstract][Full Text] [Related]
4. Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes.
Sugitani I; Toda K; Yamada K; Yamamoto N; Ikenaga M; Fujimoto Y
World J Surg; 2010 Jun; 34(6):1222-31. PubMed ID: 20066418
[TBL] [Abstract][Full Text] [Related]
5. [Is total thyroidectomy and lymph node excision as therapy of differentiated thyroid gland carcinomas in childhood justified?].
Witte J; Goretzki PE; Simon D; Röher HD
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():196-8. PubMed ID: 9101829
[TBL] [Abstract][Full Text] [Related]
6. Classical and follicular variant of papillary thyroid carcinoma: a comparative study on clinicopathologic features and long-term outcome.
Lang BH; Lo CY; Chan WF; Lam AK; Wan KY
World J Surg; 2006 May; 30(5):752-8. PubMed ID: 16680590
[TBL] [Abstract][Full Text] [Related]
7. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
8. Aggressiveness and outcome of papillary thyroid carcinoma (PTC) versus microcarcinoma (PMC): a mono-institutional experience.
Cappelli C; Castellano M; Braga M; Gandossi E; Pirola I; De Martino E; Agosti B; Rosei EA
J Surg Oncol; 2007 Jun; 95(7):555-60. PubMed ID: 17226813
[TBL] [Abstract][Full Text] [Related]
9. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.
Chow SM; Law SC; Chan JK; Au SK; Yau S; Lau WH
Cancer; 2003 Jul; 98(1):31-40. PubMed ID: 12833452
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for nodal metastasis and recurrence among patients with papillary thyroid microcarcinoma: differences in clinical relevance between nonincidental and incidental tumors.
Pisanu A; Reccia I; Nardello O; Uccheddu A
World J Surg; 2009 Mar; 33(3):460-8. PubMed ID: 19123022
[TBL] [Abstract][Full Text] [Related]
11. Persistent disease in patients with papillary thyroid carcinoma and lymph node metastases after surgery and iodine-131 ablation.
Verburg FA; de Keizer B; Lam MG; de Klerk JM; Lips CJ; Borel-Rinkes IH; van Isselt JW
World J Surg; 2007 Dec; 31(12):2309-14. PubMed ID: 17952702
[TBL] [Abstract][Full Text] [Related]
12. [Draft of the best medical treatment in patients with low-risk thyroid cancer].
Vlček P; Nováková D; Vejvalka J; Zimák J; Křenek M; Vošmiková K; Smutný S; Bavor P; Astl J; Lukáš J
Vnitr Lek; 2015 Sep; 61(9):769-77. PubMed ID: 26465275
[TBL] [Abstract][Full Text] [Related]
13. Optimizing the treatment of AMES high-risk papillary thyroid carcinoma.
Lo CY; Chan WF; Lam KY; Wan KY
World J Surg; 2004 Nov; 28(11):1103-9. PubMed ID: 15490070
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in papillary microcarcinoma with emphasis on histologic subtyping: a clinicopathologic study of 148 cases.
Ghossein R; Ganly I; Biagini A; Robenshtok E; Rivera M; Tuttle RM
Thyroid; 2014 Feb; 24(2):245-53. PubMed ID: 23745671
[TBL] [Abstract][Full Text] [Related]
15. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.
Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E
Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant Radioactive iodine 131 ablation in papillary microcarcinoma of thyroid: Saudi Arabian experience [corrected].
Al-Qahtani KH; Al Asiri M; Tunio MA; Aljohani NJ; Bayoumi Y; Fatani H; AlHadab A
J Otolaryngol Head Neck Surg; 2015 Dec; 44():51. PubMed ID: 26621255
[TBL] [Abstract][Full Text] [Related]
17. Clinically unsuspected papillary microcarcinomas of the thyroid: a common finding with favorable biology?
Dunki-Jacobs E; Grannan K; McDonough S; Engel AM
Am J Surg; 2012 Feb; 203(2):140-4. PubMed ID: 21600560
[TBL] [Abstract][Full Text] [Related]
18. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
19. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period.
Hay ID; Grant CS; van Heerden JA; Goellner JR; Ebersold JR; Bergstralh EJ
Surgery; 1992 Dec; 112(6):1139-46; discussion 1146-7. PubMed ID: 1455316
[TBL] [Abstract][Full Text] [Related]
20. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
